Skip to main content

Table 1 Eligibility criteria

From: Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

Inclusion criteria
Resectable pancreatic Carcinoma
Written informed consent of the patient
No evidence of active or former concurrent malignant diseases
Exclusion criteria
Previous radiotherapy to the upper abdomen
Participation in other therapeutical trials
No willingness on regular follow up care